Medtronic
Verify System to
Identify Incontinence Patients Eligible for
Sacral Neurostimulation
Urinary
Incontinence is an awkward and frustrating condition that people of all age groups can suffer from. There are some therapies in existence that can help deal with the condition, but choosing which route to take can be hit or miss. A popular solution that recently came to market involves using a neurostimulator to target the
Sacral nerves, which in turn contracts muscles within the pelvic floor. The thing is that the procedure doesn’t work for everyone and finding out that you’re **t
Eligible only after an implantation can be seriously disappointing.
Medtronic, the maker of the InterStim
Sacral nerve stimulator for
Incontinence management, received FDA approval for its
Verify Evaluation
System for*identifying whether a patient will benefit from
Sacral neurostimulation. The
System has already been used in the U.S. in initial
Patients to help make a decision on whether to go with the InterStim
System or pursue other options if neurostimulation is **t appropriate.
The
Verify System, like the InterStim device, electrically stimulates the
Sacral nerves but doesn’t require a full scale implantation. Instead, a minimally invasive procedure is used to place the lead which extends to an external neurostimulator that is worn discreetly under clothing near the hips. A device that looks like a smartphone is used to adjust the therapy and evaluate how much stimulation is appropriate for the patient.
Medtronic did make an evaluation
System available before, but it was less discrete and **t as user friendly.
Flashbacks:
InterStim Sacral Nerve Stimulation for Bowel Control Is **w Option in US…;*
Medtronic’s InterStim Therapy Continues to Show Encouraging Results at 3-Year Follow Up…;*
Sacral Nerve Stimulation to Treat Fecal Incontinence Shows Promise…
Press release:
New Evaluation System Leads to Incontinence Relief…
